Suppr超能文献

RNA 适体特异性抑制 FGF5 诱导的细胞增殖。

Specific inhibition of FGF5-induced cell proliferation by RNA aptamers.

机构信息

Department of Life Science, Faculty of Advanced Engineering, Chiba Institute of Technology, 2-17-1 Tsudanuma, Narashino-shi, Chiba, 275-0016, Japan.

Advangen Inc, 4-6-3 Kashiwa, Kashiwa-shi, Chiba, 277-0005, Japan.

出版信息

Sci Rep. 2021 Feb 3;11(1):2976. doi: 10.1038/s41598-021-82350-w.

Abstract

Fibroblast growth factor 5 (FGF5) is a crucial regulator of hair growth and an oncogenic factor in several human cancers. To generate FGF5 inhibitors, we performed Systematic Evolution of Ligands by EXponential enrichment and obtained novel RNA aptamers that have high affinity to human FGF5. These aptamers inhibited FGF5-induced cell proliferation, but did not inhibit FGF2-induced cell proliferation. Surface plasmon resonance demonstrated that one of the aptamers, F5f1, binds to FGF5 tightly (K = 0.7 ± 0.2 nM), but did not fully to FGF1, FGF2, FGF4, FGF6, or FGFR1. Based on sequence and secondary structure similarities of the aptamers, we generated the truncated aptamer, F5f1_56, which has higher affinity (K = 0.118 ± 0.003 nM) than the original F5f1. Since the aptamers have high affinity and specificity to FGF5 and inhibit FGF5-induced cell proliferation, they may be candidates for therapeutic use with FGF5-related diseases or hair disorders.

摘要

成纤维细胞生长因子 5 (FGF5) 是毛发生长的关键调节因子,也是几种人类癌症中的致癌因子。为了生成 FGF5 抑制剂,我们进行了指数富集的配体系统进化,获得了对人 FGF5 具有高亲和力的新型 RNA 适体。这些适体抑制了 FGF5 诱导的细胞增殖,但不抑制 FGF2 诱导的细胞增殖。表面等离子体共振实验表明,其中一种适体 F5f1 与 FGF5 紧密结合(Kd=0.7±0.2 nM),但与 FGF1、FGF2、FGF4、FGF6 或 FGFR1 不完全结合。基于适体的序列和二级结构相似性,我们生成了截断的适体 F5f1_56,它比原始 F5f1 具有更高的亲和力(Kd=0.118±0.003 nM)。由于适体对 FGF5 具有高亲和力和特异性,并抑制 FGF5 诱导的细胞增殖,它们可能成为与 FGF5 相关疾病或毛发紊乱相关的治疗用途的候选物。

相似文献

1
Specific inhibition of FGF5-induced cell proliferation by RNA aptamers.
Sci Rep. 2021 Feb 3;11(1):2976. doi: 10.1038/s41598-021-82350-w.
4
Endothelial MMP14 is required for endothelial-dependent growth support of human airway basal cells.
J Cell Sci. 2015 Aug 15;128(16):2983-8. doi: 10.1242/jcs.168179. Epub 2015 Jun 26.
5
Bioinformatics analysis of evolutionary characteristics and biochemical structure of FGF5 Gene in sheep.
Gene. 2019 Jun 20;702:123-132. doi: 10.1016/j.gene.2019.03.040. Epub 2019 Mar 26.
6
RNA aptamers: a review of recent trends and applications.
Adv Biochem Eng Biotechnol. 2013;131:153-69. doi: 10.1007/10_2012_136.
7
The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells.
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1330-1334. doi: 10.1016/j.bbrc.2018.07.044. Epub 2018 Jul 11.
8
Selection of a high-affinity and in vivo bioactive ssDNA aptamer against angiotensin II peptide.
Peptides. 2016 Aug;82:101-108. doi: 10.1016/j.peptides.2016.06.004. Epub 2016 Jun 11.
9
Fibroblast growth factor-5 promotes spermatogonial stem cell proliferation via ERK and AKT activation.
Stem Cell Res Ther. 2019 Jan 22;10(1):40. doi: 10.1186/s13287-019-1139-7.
10
FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.
Oncogene. 2008 Jul 10;27(30):4180-90. doi: 10.1038/onc.2008.61. Epub 2008 Mar 24.

引用本文的文献

1
Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications.
Curr Drug Targets. 2025;26(8):551-570. doi: 10.2174/0113894501351461250301072444.
3
Genetically predicted inflammatory proteins and the risk of atrial fibrillation: a bidirectional Mendelian randomization study.
Front Cardiovasc Med. 2024 Jun 26;11:1375750. doi: 10.3389/fcvm.2024.1375750. eCollection 2024.
4
Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.
Am J Clin Exp Urol. 2023 Dec 15;11(6):452-466. eCollection 2023.
5
The Interplay between T Cells and Cancer: The Basis of Immunotherapy.
Genes (Basel). 2023 Apr 28;14(5):1008. doi: 10.3390/genes14051008.
6
A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancer.
Int J Cancer. 2023 Jul 15;153(2):364-372. doi: 10.1002/ijc.34510. Epub 2023 Apr 5.
7
Polymeric Carriers for Delivery of RNA Cancer Therapeutics.
Noncoding RNA. 2022 Aug 2;8(4):58. doi: 10.3390/ncrna8040058.
8
New developments in the biology of fibroblast growth factors.
WIREs Mech Dis. 2022 Jul;14(4):e1549. doi: 10.1002/wsbm.1549. Epub 2022 Feb 9.

本文引用的文献

1
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease.
Mol Ther Nucleic Acids. 2019 Sep 6;17:819-828. doi: 10.1016/j.omtn.2019.07.018. Epub 2019 Aug 1.
2
FGF5 promotes osteosarcoma cells proliferation via activating MAPK signaling pathway.
Cancer Manag Res. 2019 Jul 10;11:6457-6466. doi: 10.2147/CMAR.S200234. eCollection 2019.
3
Development of a Monomeric Inhibitory RNA Aptamer Specific for FGFR3 that Acts as an Activator When Dimerized.
Mol Ther Nucleic Acids. 2019 Sep 6;17:530-539. doi: 10.1016/j.omtn.2019.06.020. Epub 2019 Jul 4.
4
DNA aptamer assemblies as fibroblast growth factor mimics and their application in stem cell culture.
Chem Commun (Camb). 2019 Feb 26;55(18):2672-2675. doi: 10.1039/c8cc08080a.
5
Fibroblast growth factor-5 promotes spermatogonial stem cell proliferation via ERK and AKT activation.
Stem Cell Res Ther. 2019 Jan 22;10(1):40. doi: 10.1186/s13287-019-1139-7.
6
Downregulation of fibroblast growth factor 5 inhibits cell growth and invasion of human nonsmall-cell lung cancer cells.
J Cell Biochem. 2019 May;120(5):8238-8246. doi: 10.1002/jcb.28107. Epub 2018 Dec 5.
7
The FGF2 aptamer inhibits the growth of FGF2-FGFR pathway driven lung cancer cells.
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1330-1334. doi: 10.1016/j.bbrc.2018.07.044. Epub 2018 Jul 11.
8
FGF Family: From Drug Development to Clinical Application.
Int J Mol Sci. 2018 Jun 26;19(7):1875. doi: 10.3390/ijms19071875.
9
MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma.
EXCLI J. 2018 Jan 15;17:102-112. doi: 10.17179/excli2017-932. eCollection 2018.
10
Characterisation of an aptamer against the Runt domain of AML1 (RUNX1) by NMR and mutational analyses.
FEBS Open Bio. 2018 Jan 2;8(2):264-270. doi: 10.1002/2211-5463.12368. eCollection 2018 Feb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验